Patent details

EP2709991 Title: Use of cxcr4 antagonists for treating WHIM syndrome, myelokathexis, neutropenia and lymphocytopenia

Basic Information

Publication number:
EP2709991
PCT Application Number:
US2012037970
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127867398
PCT Publication Number:
WO2012158707
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Use of cxcr4 antagonists for treating WHIM syndrome, myelokathexis, neutropenia and lymphocytopenia
French Title of Invention:
Utilisation d'antagonistes du cxcr4 pour traiter: syndrome WHIM, myelokathexis, neutropénie et lymphocytopénie
German Title of Invention:
Verwendung von cxcr4-Antagonisten zur Behandlung von WHIM Syndrom, Myelokathexis, Neutropenia und Lymphozytopenia
SPC Number:

Dates

Filing date:
15/05/2012
Grant date:
02/09/2020
EP Publication Date:
26/03/2014
PCT Publication Date:
22/11/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/09/2020
EP B1 Publication Date:
02/09/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/05/2021
Expiration date:
15/05/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/08/2020
 
 

Name:
Genzyme Corporation
Address:
50 Binney Street, Cambridge, MA 02142, United States (US)

Name:
University of Washington
Address:
Center for Commercialization 4311 11th Avenue NE, Suite 500, Seattle, WA 98105, United States (US)

Inventor

1

Name:
BRIDGER, Gary, J.
Address:
United States (US)

2

Name:
DALE, David, C.
Address:
United States (US)

3

Name:
HSU, Frank, J.
Address:
United States (US)

Priority

Priority Number:
201161486632 P
Priority Date:
16/05/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/395; A61K 38/19; A61K 45/06; A61P 7/06; C07D 255/02;

Publication

European Patent Bulletin

Issue number:
202036
Publication date:
02/09/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages